Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 736 AL 750

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

Perez-Lloret S, Rey MV, Crispo J, Krewski D, Lapeyre-Mestre M, Montastruc JL, Rascol O.

Expert Opin Drug Saf. 2014 Mar;13(3):351-60. doi: 10.1517/14740338.2014.888057.

Protective and toxic roles of dopamine in Parkinson's disease

Segura-Aguilar J, Paris I, Muñoz P, Ferrari E, Zecca L, Zucca FA.

J Neurochem. 2014 Jun;129(6):898-915. doi: 10.1111/jnc.12686. Epub 2014 Mar 18.

Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa

Speciali DS, Corrêa JC, Luna NM, Brant R, Greve JM, de Godoy W, Baker R, Lucareli PR.

Gait Posture. 2014 Apr;39(4):1142-5. doi: 10.1016/j.gaitpost.2014.01.011. Epub 2014 Jan 30.

[Ultrahigh field MRI in context of neurological diseases]

Kuchling J, Sinnecker T, Bozin I, Dörr J, Madai VI, Sobesky J, Niendorf T, Paul F, Wuerfel J.

Nervenarzt. 2014 Apr;85(4):445-58. doi: 10.1007/s00115-013-3967-5.

Changes of oscillatory activity in the subthalamic nucleus during obsessive-compulsive disorder symptoms: two case reports

Bastin J, Polosan M, Piallat B, Krack P, Bougerol T, Chabardès S, David O.

Cortex. 2014 Nov;60:145-50. doi: 10.1016/j.cortex.2013.12.007. Epub 2014 Jan 15.

Olfactory bulb involvement in neurodegenerative diseases

Attems J, Walker L, Jellinger KA.

Acta Neuropathol. 2014 Apr;127(4):459-75. doi: 10.1007/s00401-014-1261-7. Epub 2014 Feb 20.

Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study

Cerasa A, Gioia MC, Salsone M, Donzuso G, Chiriaco C, Realmuto S, Nicoletti A, Bellavia G, Banco A, D'amelio M, Zappia M, Quattrone A.

Neurol Sci. 2014 Aug;35(8):1173-80. doi: 10.1007/s10072-014-1666-z. Epub 2014 Feb 20.

Closed-loop cortical neuromodulation in Parkinson's disease: An alternative to deep brain stimulation?

Beuter A, Lefaucheur JP, Modolo J.

Clin Neurophysiol. 2014 May;125(5):874-85. doi: 10.1016/j.clinph.2014.01.006. Epub 2014 Jan 18.

Mood and behavioural effects of subthalamic stimulation in Parkinson's disease

Castrioto A, Lhommée E, Moro E, Krack P.

Lancet Neurol. 2014 Mar;13(3):287-305. doi: 10.1016/S1474-4422(13)70294-1. Epub 2014 Feb 17.

The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology

Wang Y, Dan Y, Yang D, Hu Y, Zhang L, Zhang C, Zhu H, Cui Z, Li M, Liu Y.

J Ethnopharmacol. 2014 Apr 11;153(1):42-60. doi: 10.1016/j.jep.2014.02.013. Epub 2014 Feb 17.

Nicotinic acetylcholine receptors in human genetic disease

Schaaf CP.

Genet Med. 2014 Sep;16(9):649-56. doi: 10.1038/gim.2014.9. Epub 2014 Feb 20.

Depression and cognitive impairment in Parkinson's disease: a role for inflammation and immunomodulation?

Pessoa Rocha N, Reis HJ, Vanden Berghe P, Cirillo C.

Neuroimmunomodulation. 2014;21(2-3):88-94. doi: 10.1159/000356531. Epub 2014 Feb 14.

Therapeutic potential of targeting glutamate receptors in Parkinson's disease

Finlay C, Duty S.

J Neural Transm (Vienna). 2014 Aug;121(8):861-80. doi: 10.1007/s00702-014-1176-4. Epub 2014 Feb 21.

VPS35 Parkinson's disease phenotype resembles the sporadic disease

Struhal W, Presslauer S, Spielberger S, Zimprich A, Auff E, Bruecke T, Poewe W, Ransmayr G; Austrian VPS-35 Investigators Team.

J Neural Transm (Vienna). 2014 Jul;121(7):755-9. doi: 10.1007/s00702-014-1179-1. Epub 2014 Feb 21.

Evidence for the validity of the modified dynamic gait index across diagnostic groups

Matsuda PN, Taylor CS, Shumway-Cook A.

Phys Ther. 2014 Jul;94(7):996-1004. doi: 10.2522/ptj.20130294. Epub 2014 Feb 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias